← All organizations

Abeona Therapeutics

For profit

Also known as: Abeona Therapeutics Inc. | Abeona Therapeutics, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 28, 2025

Timeline

2010s

Jan 1, 2013
Abeona Therapeutics— Founded
Jan 1, 2014
Access Pharmaceuticals, Inc.— Acquired

Drugs by trial phase (9 distinct, 10 trials)

Phase 3 (1 own, 2 via acquisition)

Phase 2 (3 own, 2 via acquisition)

Phase 1 (0 own, 1 via acquisition)

Thiarabine

Indications

Studied for

Subsidiaries (1 direct, 3 total across the full acquisition tree)

Recent trials (5)

NCT04227106Lead sponsorPhase 3Jan 10, 2020
NCT04088734Lead sponsorPhase 1/Phase 2Oct 31, 2019
NCT03315182CollaboratorPhase 1/Phase 2Oct 16, 2017
NCT02716246CollaboratorPhase 1/Phase 2Mar 1, 2016
NCT01263379CollaboratorPhase 1/Phase 2Oct 5, 2010

Details

Founded: Cleveland, OH, US Jan 1, 2013
Last known activity: Apr 28, 2025